Technology
Health
Biotechnology

Leap Therapeutics

1,379

$1.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-1.23%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell LPTX and other stocks, options, ETFs, and crypto commission-free!

About LPTX

Leap Therapeutics, Inc. Common Stock, also called Leap Therapeutics, is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. Read More Its clinical stage programs are DKN-01, which is a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1 and TRX518, which is a monoclonal antibody targeting the glucocorticoid-induced tumor necrosis factor-related receptor, or GITR. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.

CEO
Chris K. Mirabelli
Employees
26
Headquarters
Cambridge, Massachusetts
Founded
2011
Market Cap
55.49M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
235.63K
High Today
$1.70
Low Today
$1.44
Open Price
$1.56
Volume
141.59K
52 Week High
$3.18
52 Week Low
$0.5728

Collections

Technology
Health
Biotechnology
Medical
Therapy
Biopharmaceutical
Cancer Prevention
Pharmaceutical

LPTX Earnings

-$0.57
-$0.38
-$0.19
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
-$0.32 per share
Actual
-$0.32 per share

People Also Bought

Titan Pharmaceuticals

35,609

$0.265

+3.72%

Titan Pharmaceuticals

35,609

$0.265

+3.72%

Onconova Therapeutics

26,200

$0.3101

-3.96%

Verastem

16,899

$2.41

-5.86%

Advaxis

11,400

$0.546

-7.46%

You May Also Like

TATYY
NVRO
CMBM
DRUA
DSU
ACWX
SRE
DTEA
ATOM
BKCC
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy LPTX

Market Price$1.61
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell LPTX stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up